{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:21:32Z","timestamp":1789586492514,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Korean Health Technology R&D Project","award":["HI13C0891"],"award-info":[{"award-number":["HI13C0891"]}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI16C1554"],"award-info":[{"award-number":["HI16C1554"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiological Methods"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.mimet.2017.11.007","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T23:00:41Z","timestamp":1510268441000},"page":"111-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Detection of resistance to fluoroquinolones and injectable drugs among antituberculosis drugs by allele-specific primer extension on a microsphere-based platform"],"prefix":"10.1016","volume":"144","author":[{"given":"Kyungjong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Seong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Baeg","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mimet.2017.11.007_bb0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.42.5.1295","article-title":"Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis","volume":"42","author":"Alangaden","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2017.11.007_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3343\/alm.2015.35.5.494","article-title":"Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar","volume":"35","author":"Aung","year":"2015","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.mimet.2017.11.007_bb0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3343\/alm.2015.35.3.356","article-title":"Comparison of AdvanSure TB\/NTM PCR and COBAS TaqMan MTB PCR for detection of Mycobacterium tuberculosis complex in routine clinical practice","volume":"35","author":"Cho","year":"2015","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.mimet.2017.11.007_bb0020","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/jac\/dkv499","article-title":"Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis","volume":"71","author":"Coeck","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mimet.2017.11.007_bb0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S2213-2600(16)30433-7","article-title":"Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.mimet.2017.11.007_bb0030","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5588\/ijtld.13.0776","article-title":"Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis","volume":"18","author":"Dowdy","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.mimet.2017.11.007_bb0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes","volume":"42","author":"Falzon","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.mimet.2017.11.007_bb0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.01865-16","article-title":"Evaluation of the GenoType MTBDRsl version 2.0 assay for second-line drug resistance detection of Mycobacterium tuberculosis isolates in South Africa","volume":"55","author":"Gardee","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2017.11.007_bb0045","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1128\/AAC.00102-13","article-title":"Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in rural China","volume":"57","author":"Hu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2017.11.007_bb0050","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1128\/JCM.00039-12","article-title":"Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study","volume":"50","author":"Ignatyeva","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2017.11.007_bb0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3343\/alm.2015.35.5.487","article-title":"Detection of first-line anti-tuberculosis drug resistance mutations by allele-specific primer extension on a microsphere-based platform","volume":"35","author":"Lee","year":"2015","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.mimet.2017.11.007_bb0060","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1128\/JCM.00803-09","article-title":"Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex","volume":"47","author":"Lin","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2017.11.007_bb0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CLEP.S35839","article-title":"Extensively drug-resistant tuberculosis: epidemiology and management","volume":"6","author":"Matteelli","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.mimet.2017.11.007_bb0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"key":"10.1016\/j.mimet.2017.11.007_bb0075","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/AAC.43.8.2000","article-title":"Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones","volume":"43","author":"Pestova","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.mimet.2017.11.007_bb0080","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.mimet.2017.11.007_bb0085","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1128\/JCM.03005-13","article-title":"Comparison of Xpert MTB\/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis","volume":"52","author":"Rufai","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2017.11.007_bb0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2180-14-165","article-title":"Molecular characterization of amikacin, kanamycin and capreomycin resistance in M\/XDR-TB strains isolated in Thailand","volume":"14","author":"Sowajassatakul","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.mimet.2017.11.007_bb0095","doi-asserted-by":"crossref","first-page":"41486","DOI":"10.1038\/srep41486","article-title":"Rapid sputum multiplex detection of the M. tuberculosis complex (MTBC) and resistance mutations for eight antibiotics by nucleotide MALDI-TOF MS","volume":"7","author":"Su","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mimet.2017.11.007_bb0100","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/JCM.36.5.1220-1225.1998","article-title":"Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene","volume":"36","author":"Suzuki","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.mimet.2017.11.007_bb0105","author":"World Health Organization"},{"key":"10.1016\/j.mimet.2017.11.007_bb0110","series-title":"Global Tuberculosis Report 2016","author":"World Health Organization","year":"2016"}],"container-title":["Journal of Microbiological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701217303007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701217303007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T23:56:26Z","timestamp":1759103786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167701217303007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":22,"alternative-id":["S0167701217303007"],"URL":"https:\/\/doi.org\/10.1016\/j.mimet.2017.11.007","relation":{},"ISSN":["0167-7012"],"issn-type":[{"value":"0167-7012","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of resistance to fluoroquinolones and injectable drugs among antituberculosis drugs by allele-specific primer extension on a microsphere-based platform","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mimet.2017.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}